Aceragen (FRA:V9Z) Interest Expense : €-0.17 Mil (TTM As of Mar. 2023)

View and export this data going back to . Start your Free Trial

What is Aceragen Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aceragen's interest expense for the three months ended in Mar. 2023 was € -0.17 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2023 was €-0.17 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Aceragen's Operating Income for the three months ended in Mar. 2023 was € -6.95 Mil. Aceragen's Interest Expense for the three months ended in Mar. 2023 was € -0.17 Mil. Aceragen did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aceragen Interest Expense Historical Data

The historical data trend for Aceragen's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aceragen Interest Expense Chart

Aceragen Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.01

Aceragen Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-0.17

Aceragen Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.17 Mil.

Aceragen (FRA:V9Z) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aceragen's Interest Expense for the three months ended in Mar. 2023 was €-0.17 Mil. Its Operating Income for the three months ended in Mar. 2023 was €-6.95 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2023 was €0.25 Mil.

Aceragen's Interest Coverage for the quarter that ended in Mar. 2023 is calculated as

Aceragen did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Aceragen (FRA:V9Z) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aceragen Inc (FRA:V9Z) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

505 Eagleview Boulevard, Suite 212, Exton, PA, USA, 19341

Website

https://www.aceragen.com

Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.

Aceragen (FRA:V9Z) Headlines

No Headlines